149 related articles for article (PubMed ID: 32034698)
1. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes.
Gobbi E; De Francesco MA; Piccinelli G; Caruso A; Bardellini E; Majorana A
Eur Arch Paediatr Dent; 2020 Dec; 21(6):673-677. PubMed ID: 32034698
[TBL] [Abstract][Full Text] [Related]
2. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora.
Mulla M; Mulla M; Hegde S; Koshy AV
BMC Oral Health; 2021 Aug; 21(1):408. PubMed ID: 34412595
[TBL] [Abstract][Full Text] [Related]
4.
Sulistiowati CP; Suhartono M; Rahmawati DF; Ulfah N; Supandi SK; Wijaksana IKE; Abullais SS; Dhadse P
Front Biosci (Landmark Ed); 2023 May; 28(5):106. PubMed ID: 37258475
[TBL] [Abstract][Full Text] [Related]
5. Interaction between Lactobacillus reuteri and periodontopathogenic bacteria using in vitro and in vivo (G. mellonella) approaches.
Santos TA; Scorzoni L; Correia R; Junqueira JC; Anbinder AL
Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 32845308
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Monotherapy with
Salinas-Azuceno C; Martínez-Hernández M; Maldonado-Noriega JI; Rodríguez-Hernández AP; Ximenez-Fyvie LA
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805491
[TBL] [Abstract][Full Text] [Related]
7. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
Park JA; Lee GR; Lee JY; Jin BH
Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia.
Baca-Castañón ML; De la Garza-Ramos MA; Alcázar-Pizaña AG; Grondin Y; Coronado-Mendoza A; Sánchez-Najera RI; Cárdenas-Estrada E; Medina-De la Garza CE; Escamilla-García E
Probiotics Antimicrob Proteins; 2015 Mar; 7(1):1-8. PubMed ID: 25422124
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
10. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
Karaçam S; Tunçer S
Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
[TBL] [Abstract][Full Text] [Related]
11. In vitro antagonistic growth effects of Lactobacillus fermentum and lactobacillus salivarius and their fermentative broth on periodontal pathogens.
Chen LJ; Tsai HT; Chen WJ; Hsieh CY; Wang PC; Chen CS; Wang L; Yang CC
Braz J Microbiol; 2012 Oct; 43(4):1376-84. PubMed ID: 24031966
[TBL] [Abstract][Full Text] [Related]
12. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Söderling EM; Marttinen AM; Haukioja AL
Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
[TBL] [Abstract][Full Text] [Related]
13. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
[TBL] [Abstract][Full Text] [Related]
15. The antimicrobial effect of
Ananda N; Suniarti DF; Bachtiar EW
F1000Res; 2023; 12():1495. PubMed ID: 38434653
[TBL] [Abstract][Full Text] [Related]
16. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion.
Prince T; McBain AJ; O'Neill CA
Appl Environ Microbiol; 2012 Aug; 78(15):5119-26. PubMed ID: 22582077
[TBL] [Abstract][Full Text] [Related]
18. [Development of biotechnology of fermented milk product with
Semenikhina VF; Rozhkova IV; Begunova AV; Fedorova TV; Shirshova TI
Vopr Pitan; 2018; 87(5):52-62. PubMed ID: 30592890
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial effect of probiotic bacteriocins on
Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.
Kang MS; Oh JS; Lee HC; Lim HS; Lee SW; Yang KH; Choi NK; Kim SM
J Microbiol; 2011 Apr; 49(2):193-9. PubMed ID: 21538238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
